| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/23/2006 | US20060039954 Comprising two or more additional ocular-active nutrients selected from lipoic acid, omega-3 fatty acids, plant-derived compounds such as flavonoids, anthocyanins, or polyphenolics, taurine, carnitine, Coenzyme-Q10, carnosine, and nutrients that stimulate production of glutathione; macular degeneration |
| 02/23/2006 | US20060039953 Water soluble polymer such as pullulan and an antimicrobial effective amount of thymol, methyl salicylate, eucalyptol and/or menthol; killing the plaque-producing germs that cause dental plaque, gingivitis and bad breath |
| 02/23/2006 | US20060039931 Stable cream preparations of phenyl-pyridone compounds for topical application |
| 02/23/2006 | US20060039868 For use in therapy of chronic obstructive pulmonary disease and asthma; an inhalette capsule contains a mixture of coarser and fine excipient particles |
| 02/23/2006 | US20060039861 For magnetic resonance imaging (MRI); peptide modified at its N- and its C-termini, independently, with a moiety comprising a metal chelate complex; specific binding affinity for fibrin; sufficient half-life in vivo |
| 02/23/2006 | US20060037543 Enhanced feeding and growth rates of aquatic animals fed an astaxanthin product derived from marigold extract |
| 02/23/2006 | DE102005008442A1 Cosmetic, pharmaceutical or dermatological preparation, useful as decorative agents, comprises copolymer waxes comprising alkyl structural units; and optionally acid structural units and e.g. styrol and alpha-methylstyrol |
| 02/23/2006 | DE102005007980A1 Cosmetic, pharmaceutical or dermatological preparation, useful as decorative agents e.g. mascara, eyelid shade and eyeliner, comprises copolymer wax comprising e.g. heterocyclic compounds and optionally aryl compounds |
| 02/23/2006 | DE102004040104A1 Verwendung von amphiphilen Copolymerisaten als Solubilisatoren Use of amphiphilic copolymers as solubilizers |
| 02/23/2006 | DE102004039029A1 Animal feed, useful to detect the product forgery or reimport, comprises the incorporated feed material and an information that the feed is consumptional by animals |
| 02/23/2006 | DE102004038885A1 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum Aerosol formulation for inhalation containing an anticholinergic |
| 02/23/2006 | DE102004038533A1 Wasserhaltige Polymermatrix aus hydrophoben Polymeren Aqueous polymer matrix of hydrophobic polymers |
| 02/23/2006 | DE102004038131A1 Polymerizable or crosslinkable dopants with controllable chiral induction, e.g. useful in liquid crystal displays, comprising 1,3-dioxolane-4,5-dicarboxylic acid derivatives |
| 02/23/2006 | CA2583700A1 Quinone prodrug compositions and methods of use |
| 02/23/2006 | CA2577431A1 Use of amphiphilic copolymers as solubilising agents |
| 02/23/2006 | CA2577345A1 Jelly composition |
| 02/23/2006 | CA2577135A1 Deuterium depleted water (ddw) using as adjuvant in cancer therapy for cytostatics toxicity reduction |
| 02/23/2006 | CA2577039A1 Aqueous enzyme delivery system |
| 02/23/2006 | CA2576291A1 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 02/23/2006 | CA2575385A1 Aerosol formulation for inhalation, containing an anticholinergenic agent |
| 02/23/2006 | CA2575367A1 3-halo-2-oxopropionate salts and esters as novel anticancer agents |
| 02/23/2006 | CA2573262A1 Conjugates of a gm-csf moiety and a polymer |
| 02/22/2006 | EP1627885A1 Polypeptide capable of assisting digestive organ absorption |
| 02/22/2006 | EP1627645A1 Antitumor agent and process for producing the same |
| 02/22/2006 | EP1627644A1 PREPARTAION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1a PRODUC TION INHIBITOR |
| 02/22/2006 | EP1627633A1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 02/22/2006 | EP1627631A2 Morphine sulphate microgranules, method for preparing same and composition comprising same |
| 02/22/2006 | EP1627055A2 Novel uses of ppar modulators and professional apcs manipulated by the same |
| 02/22/2006 | EP1626983A2 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof |
| 02/22/2006 | EP1626748A2 Moisture curable materials for delivery of agents, methods, and medical devices |
| 02/22/2006 | EP1626741A2 Peg derivatives having an amidocarbonate linkage |
| 02/22/2006 | EP1626740A2 Drug conjugate composition |
| 02/22/2006 | EP1626739A1 Compositionss for treating infection in cattle and swine |
| 02/22/2006 | EP1626706A2 Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals |
| 02/22/2006 | EP1626705A1 Low sodium solution |
| 02/22/2006 | EP1626697A2 Pharmaceutical compositions for oral administration comprising lithium carbonate |
| 02/22/2006 | EP1587869A4 Membrane active polymers |
| 02/22/2006 | EP1384472B1 Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate |
| 02/22/2006 | EP1278818B1 Use of low ionic strength ophthalmic compositions |
| 02/22/2006 | EP1251857B1 Pharmaceutical parenteral composition containing a bisphosphonate |
| 02/22/2006 | EP1244805B1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 02/22/2006 | EP1208086B1 Benzamide formulation with histone deacetylase inhibitor activity |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1067914B1 Composition and method of preparing microparticles of water-insoluble substances |
| 02/22/2006 | EP1051193B1 Anhydrous topical skin preparation comprising ketoconazole |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | EP0938301B2 Directly compressible lactitol and method |
| 02/22/2006 | CN1738911A Solid surface for biomolecule delivery and high-throughput assay |
| 02/22/2006 | CN1738815A 整联蛋白靶向的影像剂 Integrin targeting imaging agent |
| 02/22/2006 | CN1738647A Extruded foodstuffs having maintenance level actives |
| 02/22/2006 | CN1738645A Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 02/22/2006 | CN1738642A Method of obtaining conjugate vaccines and vaccine compositions containing same |
| 02/22/2006 | CN1738612A Drinkable preparation comprising ketoprofen and the use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 02/22/2006 | CN1738609A Adhesive composition for dermal patch and production process thereof |
| 02/22/2006 | CN1738603A Emulsive water-soluble concentrates |
| 02/22/2006 | CN1738601A Dermastick thickened ointment |
| 02/22/2006 | CN1738599A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/22/2006 | CN1738598A Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles |
| 02/22/2006 | CN1738549A Method of inhibiting water content variation of composition and use thereof |
| 02/22/2006 | CN1738548A Compositions containing coenzyme q10 |
| 02/22/2006 | CN1736980A Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 02/22/2006 | CN1736489A Process for preparing nano-granule of albumin |
| 02/22/2006 | CN1736488A Method for preparing nanometer sized rapamycin/chitosan enveloped carrier |
| 02/22/2006 | CN1736487A Bioimplant formulation |
| 02/22/2006 | CN1736484A Method for preparing nanometer particle of galactose sodium alginate-polylysine |
| 02/22/2006 | CN1736384A Mixture of higher primary aliphatic alcohols with acetylsalicylic acid and pharmaceutical formulation |
| 02/22/2006 | CN1736366A Preparation process and application of inorganic salt nanometer particle containing biological active material and enveloped Chinese medicinal ingredient |
| 02/22/2006 | CN1736365A Method for preparing nanometer particles of galactose hydroxyapatite-polylysine |
| 02/22/2006 | CN1243079C Function cubic liquid crystalline phase precursor and its preparation and using method |
| 02/22/2006 | CN1243011C Cholesterin derivative containing azobenzol group and its synthesis and use |
| 02/22/2006 | CN1243001C Method of manufacturing sertindole |
| 02/22/2006 | CN1242991C Aporphine esters and their use in therapy |
| 02/22/2006 | CN1242810C Drug composition, its preparation method and use |
| 02/22/2006 | CN1242750C Biodegradable and biocompatible polymeric microsphores encapsulating salmonella enteritidis bacteria |
| 02/22/2006 | CN1242746C Medicine compound contg. troxeration |
| 02/22/2006 | CN1242745C Slow release (controlled releuse) preparation of doufuguosu |
| 02/21/2006 | US7002027 Drug delivery enhancing agents with cholic acid and monosaccharide groups for treating cancer by gene therapy; tissue or organs having an epithelial membrane |
| 02/21/2006 | US7001991 transferrin-doxorubicin linked with glutaraldehyde; low-toxicity, side-effect reduction |
| 02/21/2006 | US7001989 Conjugates comprising two active agents |
| 02/21/2006 | US7001987 Hydrogel with controllable mechanical, chemical, and biological properties and method for making same |
| 02/21/2006 | US7001922 Peptide deformylase activated prodrugs |
| 02/21/2006 | US7001920 Psychological disorders; antidepressant |
| 02/21/2006 | US7001892 Pharmaceutical materials and methods for their preparation and use |
| 02/21/2006 | US7001891 Biodegradable polycation composition for delivery of an anionic macromolecule |
| 02/21/2006 | US7001889 Comprises praziquantel and/or pyrantel in solvent with thickener for improved bioavailability |
| 02/21/2006 | US7001764 Compositions comprising tissue specific adenoviral vectors |
| 02/21/2006 | US7001617 Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| 02/21/2006 | US7001614 Liposome complexes for increased systemic delivery |
| 02/21/2006 | US7001612 For restoration of electrolyte balance due to sweating in the absence of strenuous physical exertion; beverages |
| 02/21/2006 | US7001611 Using astaxanthin; sleep disorders |
| 02/21/2006 | US7001607 polyaphron gel containing water-soluble fluorinated surfactant, water, and a nonpolar component, in particular, a fluorocarbon or a silicone oil; introducing gel into conjunctival sac of the eye |
| 02/21/2006 | US7001601 keyhole limpet hemocyanin (KLH) and adjuvant (QS-21; saponin derivative); immunogens; for treatment of melanomas |
| 02/21/2006 | US7001591 Cosmetic preparations containing silicone compounds and esters of hydroxycarboxylic acids and alk(en)yl oligoglycosides |
| 02/21/2006 | US7001589 comprises liquid core (containing hydrocarbon) and water soluble polymethylacrylamides as skins/envelopes; microencapsulation; kits |
| 02/21/2006 | US7001582 Micronized barium sulfate |
| 02/21/2006 | CA2356306C Sulfated phosphatidylinositols, their preparation and use |
| 02/21/2006 | CA2193543C Sodium hyaluronate based ophthalmic formulation for use in eye surgery |
| 02/16/2006 | WO2006017374A2 Nutritional supplement composition and method |
| 02/16/2006 | WO2006016695A1 Preventive and/or remedy for hyperkalemia containing ep4 agonist |
| 02/16/2006 | WO2006016685A1 Method for producing capsinoid-containing microcapsule |